Oramed Pharmaceuticals Inc.
ORMP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001176309
No open-market purchases or sales by Oramed Pharmaceuticals Inc. insiders were filed in the last 90 days; 84 institutions reported holding it in 13F filings for Q2 2026, worth $80.7M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Oramed Pharmaceuticals Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 52 | 47 | −5 |
| Shares | 7.77M | 7.25M | −520.6K (−6.7%) |
| Value | $16.6M | $16.3M | −$320.4K (−1.9%) |
New holders (4)
Institutions that held Oramed Pharmaceuticals Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Mariner, LLC | 10,086 | $22.7K | 0.00% |
| Raymond James Financial Inc | 3,576 | $8.05K | 0.00% |
| Newbridge Financial Services Group, Inc. | 1,000 | $2.25K | 0.00% |
| Allworth Financial LP | 300 | $675 | 0.00% |
Sold out (9)
Institutions that held Oramed Pharmaceuticals Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Two Sigma Advisers, LP | 213,000 | $455.8K |
| Two Sigma Investments, LP | 64,418 | $137.9K |
| SG Americas Securities, LLC | 23,446 | $50.0K |
| N.E.W. Advisory Services LLC | 18,900 | $40.4K |
| Prelude Capital Management, LLC | 13,435 | $28.8K |
| Simplex Trading, LLC | 7,244 | $15.0K |
| Group One Trading, L.P. | 3,310 | $7.08K |
| First Horizon Advisors, Inc. | 1,750 | $3.75K |
| Tower Research Capital LLC (TRC) | 649 | $1.39K |